Physician profile
Eric Norenberg
NPI 1316988173
$12,043.70
in general payments reported to CMS, 2019-2025
50 companies · $64.31 in 2025
The $64.31 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,741 · 2020: $1,627 · 2021: $2,952 · 2022: $2,369 · 2023: $1,827 · 2024: $1,465 · 2025: $64.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,271 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,270.59 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,337.30 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,024.03 | 2019-2024 | Breztri, Farxiga, Airsupra |
| Amarin Pharma, INC. | $912.58 | 2019-2022 | |
| Lilly USA, LLC | $776.76 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $760.44 | 2019-2024 | |
| Glaxosmithkline, LLC. | $664.58 | 2020-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Optinose US, INC. | $650.57 | 2019-2024 | |
| Abbott Laboratories | $543.15 | 2021-2025 | Freestyle Libre 3 |
| Pfizer INC. | $472.66 | 2019-2024 | |
| Amgen INC. | $460.58 | 2019-2024 | Repatha, Otezla, Evenity |
| Janssen Pharmaceuticals, INC | $436.68 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $410.34 | 2019-2023 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $379.21 | 2019-2024 | Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $293.17 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $286.49 | 2019-2021 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Norenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.